R J Landers

1.7k total citations
21 papers, 1.4k citations indexed

About

R J Landers is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, R J Landers has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in R J Landers's work include Angiogenesis and VEGF in Cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Molecular Biology Techniques and Applications (3 papers). R J Landers is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Molecular Biology Techniques and Applications (3 papers). R J Landers collaborates with scholars based in United Kingdom, Ireland and United States. R J Landers's co-authors include Adrian L. Harris, Claire E. Lewis, Russell Leek, James Underwood, J. S. Lewis, Janice A. Royds, Nicholas Hunt, Stephen B. Fox, F Ng and John O’Leary and has published in prestigious journals such as British Journal of Cancer, Frontiers in Immunology and IEEE Journal of Solid-State Circuits.

In The Last Decade

R J Landers

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R J Landers United Kingdom 12 622 581 549 398 187 21 1.4k
Carter Van Waes United States 18 647 1.0× 321 0.6× 821 1.5× 408 1.0× 115 0.6× 28 1.5k
Osamu Hosono Japan 23 623 1.0× 352 0.6× 491 0.9× 239 0.6× 106 0.6× 70 1.4k
Stephen M. Thirdborough United Kingdom 21 494 0.8× 562 1.0× 452 0.8× 261 0.7× 101 0.5× 31 1.3k
T Castel Spain 20 833 1.3× 363 0.6× 554 1.0× 204 0.5× 148 0.8× 62 1.3k
Ravshan Ataullakhanov Russia 13 562 0.9× 543 0.9× 472 0.9× 240 0.6× 125 0.7× 47 1.3k
Meggy Suarez‐Carmona Belgium 16 624 1.0× 396 0.7× 509 0.9× 331 0.8× 98 0.5× 22 1.3k
Kyle K. Payne United States 22 699 1.1× 765 1.3× 544 1.0× 227 0.6× 109 0.6× 42 1.5k
Véronique Winnepenninckx Netherlands 23 985 1.6× 385 0.7× 935 1.7× 270 0.7× 261 1.4× 67 2.0k
Maria Antonia Frassanito Italy 30 738 1.2× 723 1.2× 1.3k 2.3× 400 1.0× 184 1.0× 68 2.5k
Rudolf Herbst Germany 22 1.1k 1.8× 409 0.7× 604 1.1× 175 0.4× 375 2.0× 70 1.9k

Countries citing papers authored by R J Landers

Since Specialization
Citations

This map shows the geographic impact of R J Landers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R J Landers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R J Landers more than expected).

Fields of papers citing papers by R J Landers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R J Landers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R J Landers. The network helps show where R J Landers may publish in the future.

Co-authorship network of co-authors of R J Landers

This figure shows the co-authorship network connecting the top 25 collaborators of R J Landers. A scholar is included among the top collaborators of R J Landers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R J Landers. R J Landers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mullally, William, Fiachra Cooke, V. E. Abernethy, et al.. (2022). Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma. Frontiers in Immunology. 13. 871217–871217. 9 indexed citations
2.
Hafidh, Maky, et al.. (2006). The role of fungi in the etiology of chronic rhinosinusitis: A prospective study. Auris Nasus Larynx. 34(2). 185–189. 13 indexed citations
3.
Landers, R J & S.S. Mahant-Shetti. (2005). Multiplexer-Based Architecture for High-Density, Low-Power Gate Arrays. 33–34.
4.
Lewis, J. S., R J Landers, James Underwood, Adrian L. Harris, & Claire E. Lewis. (2000). Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. The Journal of Pathology. 192(2). 150–158. 311 indexed citations
5.
Leek, Russell, Nicholas Hunt, R J Landers, et al.. (2000). Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. The Journal of Pathology. 190(4). 430–436. 258 indexed citations
6.
7.
Leek, Russell, Nicholas Hunt, R J Landers, et al.. (2000). Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. The Journal of Pathology. 190(4). 430–436. 21 indexed citations
8.
Leek, Russell, R J Landers, Adrian L. Harris, & Claire E. Lewis. (1999). Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. British Journal of Cancer. 79(5-6). 991–995. 373 indexed citations
9.
Leek, Russell, et al.. (1998). Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. British Journal of Cancer. 77(12). 2246–2251. 176 indexed citations
10.
O’Leary, John, et al.. (1998). Human papillomavirus and mixed epithelial tumors of the endometrium. Human Pathology. 29(4). 383–389. 39 indexed citations
11.
O’Leary, John, R J Landers, & Runjan Chetty. (1997). In situ amplification in cytological preparations. Cytopathology. 8(3). 148–160. 1 indexed citations
12.
O’Leary, John, et al.. (1997). Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.. Journal of Clinical Pathology. 50(11). 896–903. 7 indexed citations
13.
O’Leary, John, R J Landers, Michael J. Crowley, et al.. (1997). Genotypic mapping of HPV and assessment of EBV prevalence in endocervical lesions.. Journal of Clinical Pathology. 50(11). 904–910. 10 indexed citations
14.
Landers, R J, et al.. (1996). A flexible gate array architecture for high-speed and high-density applications. IEEE Journal of Solid-State Circuits. 31(3). 430–436. 1 indexed citations
15.
O’Leary, John, et al.. (1996). In situ amplification: its application to diagnostic pathology. Current Diagnostic Pathology. 3(4). 201–210. 1 indexed citations
16.
Landers, R J, et al.. (1995). A multiplexer-based architecture for high-density, low-power gate arrays. IEEE Journal of Solid-State Circuits. 30(4). 392–396. 2 indexed citations
17.
O’Leary, John, R J Landers, Michael J. Crowley, et al.. (1994). The importance of fixation procedures on DNA template and its suitability for solution-phase polymerase chain reaction and PCR in situ hybridization. The Histochemical Journal. 26(4). 337–346. 50 indexed citations
18.
O’Leary, John, et al.. (1994). PCR in situ hybridisation detection of HPV 16 in fixed CaSki and fixed SiHa cell lines.. Journal of Clinical Pathology. 47(10). 933–938. 24 indexed citations
19.
O’Leary, John, et al.. (1994). New nucleic acid amplification techniques in diagnostic pathology. Journal of the European Academy of Dermatology and Venereology. 3(1). 78–86. 1 indexed citations
20.
Landers, R J, John O’Leary, Michael J. Crowley, et al.. (1993). Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix.. Journal of Clinical Pathology. 46(10). 931–935. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carter Van Waes Breakdown of academic impact, for papers by Osamu Hosono Breakdown of academic impact, for papers by Stephen M. Thirdborough Breakdown of academic impact, for papers by T Castel Breakdown of academic impact, for papers by Ravshan Ataullakhanov Breakdown of academic impact, for papers by Meggy Suarez‐Carmona Breakdown of academic impact, for papers by Kyle K. Payne Breakdown of academic impact, for papers by Véronique Winnepenninckx Breakdown of academic impact, for papers by Maria Antonia Frassanito Breakdown of academic impact, for papers by Rudolf Herbst
Rankless by CCL
2026